Quantum BioPharma Ltd.
QNTM
$18.09
$0.0350.19%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -197.35% | -350.60% | -284.39% | -261.12% | 43.32% |
| Total Depreciation and Amortization | 3.36% | 7.99% | -7.69% | -17.71% | -87.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15,252.05% | 965.83% | -893.75% | 80.84% | -96.00% |
| Change in Net Operating Assets | -146.57% | 151.09% | 926.05% | -46.04% | 1,126.31% |
| Cash from Operations | -221.37% | -115.91% | 1.87% | -102.08% | 82.72% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -284.41% | -6,009.50% | -- | -1,049.14% | -- |
| Cash from Investing | -284.41% | -6,009.50% | -- | -1,184.68% | -- |
| Total Debt Issued | 12,245.28% | 984.32% | -- | -- | -- |
| Total Debt Repaid | -5,510.27% | -58.50% | -17.79% | 91.61% | 73.31% |
| Issuance of Common Stock | -92.09% | -84.51% | -- | -- | 15,791.38% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -30.09% | 450.99% | 9,891.67% | 12,395.44% | 4,380.05% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -202.24% | -73.65% | 427.93% | 90.85% | 155.64% |